683 CAPITAL MANAGEMENT LLC
Q2 2024 Form 13-F

NEW YORK, NEW YORK
CIK 0001404574 · CRD 156181 · SEC-registered investment adviser
Consolidated report · includes 1 manager since Q2 2013
$1.3B Reported Value Total

683 CAPITAL MANAGEMENT, LLC reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $1,951,751,504, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
2 funds · $2.4B gross asset value
Hedge Fund: $2.4B
Source: Form ADV filed 2026-03-30
Reported value
$1.3B
Quarter over quarter
-4.8%
Holdings
124
Top-10 concentration
42.9%

Filing Structure

Reports holdings for

Key People

Form ADV owners & control persons
John Andrew Levin
MANAGING MEMBER
Ari Jonathan Zweiman
MANAGING MEMBER
Joseph S Patt
PARTNER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2024 13F record

Q2 2024 13F filing summary

Q2 2024 Form 13F portfolio summary
Period of report June 30, 2024
Filed August 14, 2024
Form 13F-HR
Reported value $1.3B
Positions 124
Change in reported value -3.2%
New positions 21
Exited positions 12
Position turnover 24.3%
Top-10 concentration 42.9%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
122 $2.4B
Q2 2026 13F
Filed Aug 14, 2026
125 $2.0B
Q1 2026 13F
Filed May 15, 2026
204 $1.9B
Q4 2025 13F
Filed Feb 17, 2026
201 $2.3B
Q3 2025 13F
Filed Nov 14, 2025
113 $1.9B
Q2 2025 13F
Filed Aug 14, 2025
111 $1.5B
Q1 2025 13F
Filed May 15, 2025
114 $1.4B
Q4 2024 13F
Filed Feb 14, 2025
205 $1.6B
Q3 2024 13F
Filed Nov 14, 2024
124 $1.3B
Q2 2024 13F
Filed Aug 14, 2024
124 $1.3B
Q1 2024 13F
Filed May 15, 2024
118 $1.4B
Q4 2023 13F
Filed Feb 14, 2024
236 $1.2B
Q3 2023 13F
Filed Nov 14, 2023
127 $1.3B
Q2 2023 13F
Filed Aug 14, 2023
135 $1.4B
Q1 2023 13F
Filed May 15, 2023
263 $1.3B
Q4 2022 13F
Filed Feb 14, 2023
290 $1.2B
Q3 2022 13F
Filed Nov 14, 2022
231 $1.3B
Q2 2022 13F
Filed Aug 15, 2022
260 $1.4B
Q1 2022 13F
Filed May 16, 2022
342 $1.9B
Q4 2021 13F
Filed Feb 14, 2022
327 $2.7B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2024

Largest Q2 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 LLY P ELI LILLY & CO $172.9M 13.07%
2 TSLA P TESLA INC $71.8M 5.43%
3 HGV HILTON GRAND VACATIONS INC $52.6M 3.97%
4 COF CAPITAL ONE FINL CORP $46.4M 3.51%
5 SN SHARKNINJA INC $45.1M 3.41%
6 ERO ERO COPPER CORP $42.7M 3.23%
7 BWA BORGWARNER INC $35.5M 2.68%
8 CVNA CARVANA CO $35.4M 2.68%
9 OXYWS OCCIDENTAL PETE CORP $35.2M 2.66%
10 ALNY P ALNYLAM PHARMACEUTICALS INC $29.9M 2.26%
11 MRNA P MODERNA INC $28.7M 2.17%
12 WVE WAVE LIFE SCIENCES LTD $26.6M 2.01%
13 TGTX TG THERAPEUTICS INC $24.9M 1.88%
14 BBIO 2.5 03/15/27 BRIDGEBIO PHARMA INC $23.2M 1.75%
15 INSM 0.75 06/01/28 INSMED INC $22.1M 1.67%
16 COI COGENT COMMUNICATIONS HLDGS $21.2M 1.6%
17 PTGX PROTAGONIST THERAPEUTICS INC $20.9M 1.58%
18 XHR XENIA HOTELS & RESORTS INC $19.0M 1.43%
19 VKTX VIKING THERAPEUTICS INC $18.0M 1.36%
20 MREO MEREO BIOPHARMA GROUP PLC $18.0M 1.36%

Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings